KOSELUGO

Capsule, hard, 25mg
RxActive license

Active substance (INN)

selumetinib

Pharmaceutical form

Pharmaceutical formCapsule, hard
Strength25mg
PackagingUkupno 60 kapsula tvrdih u bočici plastičnoj u kartonskoj kutiji
ManufacturerAstraZeneca AB, Sweden
Therapeutic groupAntineoplastic and immunomodulating agents (L01EE04)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateFebruary 24, 2026

Analogs in Montenegro

1

Other medicines with the same active substance

KOSELUGORx
Capsule, hard, 10mgAstraZeneca AB
Source: CInMED register